三优生物SanyouBio Mediaroom

Sanyou Bio: Sanyou's Intelligence-Enabled Innovative Biologics R&D Platform Leads in the New Era of Biological Drug Development

SHANGHAI, March 27, 2024 /PRNewswire/ -- Dr. Guojun Lang, founder and CEO of Sanyou Biopharmaceutic...

2024-03-27 20:00 1309

Sanyou Bio and BioGeometry join forces to create a next-generation Antibody Drug Discovery Platform driven by AIGC

SHANGHAI, March 18, 2024 /PRNewswire/ -- Recently, BioGeometry and Sanyou Bio jointly announced the...

2024-03-19 08:00 980

Sanyou Biopharmaceuticals Launches Advanced Intelligent R&D Service Platform

SHANGHAI, March 12, 2024 /PRNewswire/ -- Sanyou Biopharmaceutical Co., Ltd. is delighted to announc...

2024-03-13 09:00 1308

Blossoming Flowers at the Top of the Biopharmaceutical Tree -- Reflections on the Flourishing of Sanyou's 4C Business

SHANGHAI, Feb. 2, 2024 /PRNewswire/ -- In 1996, MDS Pharma Service invested in and established the ...

2024-02-03 08:00 2094

Sanyou Super Trillion Peptide Molecule Discovery Platform Officially Launched Today

SHANGHAI, Jan. 19, 2024 /PRNewswire/ -- On January 13, 2024 local time, Sanyou Biopharmaceuticals (...

2024-01-20 08:00 2260

Sanyou's "STAL Platform" is a significant advancement in the field of drug discovery.

SHANGHAI, Nov. 17, 2023 /PRNewswire/ -- Sanyou's "STAL Innovative Biologics Drug Discovery Platform...

2023-11-18 08:00 2790

Sanyou Bio Congratulates KangaBio on their IND Approval for Next-Generation IL-12 Prodrug Cancer Immunotherapy

SHANGHAI, Nov. 4, 2023 /PRNewswire/ -- On October 26, 2023, KangaBio announced that the U.S. FDA ha...

2023-11-05 08:00 2198

Congratulations to Sanyou Bio for achieving ISO9001 & IPMS certifications

SHANGHAI, Oct. 17, 2023 /PRNewswire/ -- Sanyou Biopharmaceuticals Co., Ltd is pleased to announce i...

2023-10-17 21:00 1260

Double Honors: Sanyou Bio Earns "Most Trusted Biopharmaceutical CXO Partner" and "Most Influential Partner of the Year" Awards

SHANGHAI, Sept. 20, 2023 /PRNewswire/ -- Sanyou Bio's consecutive wins reflect our clients' trust, ...

2023-09-20 20:00 1194

Sanyou Biopharmaceuticals and Sinorda Biomedicine signed Strategic Cooperation Agreement for Advancing Innovative Drug Research and Development

SHANGHAI, Aug. 22, 2023 /PRNewswire/ -- Sanyou Biopharmaceuticals (Shanghai) Co., Ltd. (referred to...

2023-08-22 20:00 1628

Sanyou Forms Partnership with Hangzhou Zhongmei Huadong Pharmaceutical, Catalyzing Innovative Drug Research and Development

SHANGHAI, June 28, 2023 /PRNewswire/ -- Recently, Sanyou Biopharmaceuticals Co., Ltd. (hereinafter ...

2023-06-28 20:00 1758

Sanyou Milestones | Super Trillion Common Light Chain Antibody Discovery Platform Launched

SHANGHAI, June 11, 2023 /PRNewswire/ -- On June 12th, 2023 local time, Sanyou Biopharmaceuticals Co...

2023-06-12 08:00 1820

Sanyou Milestones | Super Trillion Common Light Chain Antibody Discovery Platform Launched

Sanyou's STAL helps researchers to explore the forefront of Life Sciences with high-impact literature publication

SHANGHAI, June 7, 2023 /PRNewswire/ -- Since the establishment of Super-Trillion Innovative Antibod...

2023-06-07 20:00 2097

Sanyou launches new European offices and continues to promote global business landscape

SHANGHAI, June 3, 2023 /PRNewswire/ -- In May 2023, following the CIC Boston branch in US, Sanyou o...

2023-06-03 20:05 3315

Sanyou Biopharmaceuticals opens Cambridge MA, US office, expanding its business outreach to a central hub of biotech network

CAMBRIDGE, Mass., March 2, 2023 /PRNewswire/ -- Sanyou Biopharmaceuticals, a leading provider of bi...

2023-03-02 18:00 1567

Sanyou Biopharmaceuticals and KangaBio established strategic collaboration to accelerate antibody drug development and innovation

SHANGHAI, Aug. 27, 2022 /PRNewswire/ -- Recently, Sanyou Biopharmaceuticals ( Shanghai) Co., Ltd. (S...

2022-08-28 08:00 3983

Sanyou Biopharmaceuticals Closed the Series B+ Financing Round of Tens of Millions of RMB Led by Huatai Zijin

SHANGHAI, Aug. 2, 2022 /PRNewswire/ -- Sanyou Biopharmaceuticals Co., Ltd. announced that it has cl...

2022-08-03 08:00 1603

Congratulations to Dragon Boat Biopharmaceutical from Sanyou Biopharmaceuticals on the NMPA acceptance of the CLDN 18.2/CD47 bsAb clinical trial application

SHANGHAI, June 25, 2022 /PRNewswire/ -- On June 15, 2022, Dragon Boat announced that its IND applic...

2022-06-26 08:00 3501

Sanyou Biopharmaceuticals forged strategic partnership with Dragon Sail Pharmaceutical to upgrade integrated innovative antibody drug R&D

SHANGHAI, June 24, 2022 /PRNewswire/ -- Sanyou Biopharmaceuticals, a biological high-tech enterpris...

2022-06-25 08:00 4871

Guojun Lang, CEO of Sanyou: New milestone in the establishment of super-trillion antibody libraries for antibody discovery of challenging targets

SHANGHAI, June 10, 2022 /PRNewswire/ -- Recently, Sanyou Biopharmaceuticals officially launched its...

2022-06-11 08:00 5878

Latest News